First Human Dose Puts ER-100's Age-Reversal Bet at Risk
Life Biosciences put ER-100 into its first patient. Now its age-reversal pitch faces the only test that matters: human data.
Jun 14, 20265 min read0 reactions0 comments
Tag archive
Life Biosciences put ER-100 into its first patient. Now its age-reversal pitch faces the only test that matters: human data.